The human pharmacology of silver sulphadiazine (AgSD)
D000287:Administration, Topical; D000818:Animals; D002056:Burns / Q000188:drug therapy*; D006801:Humans; D011552:Pseudomonas Infections / Q000517:prevention & control; D012837:Silver Sulfadiazine / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D013411:Sulfadiazine / Q000008:administration & dosage*; D014946:Wound Infection / Q000517:prevention & control
D013411:Sulfadiazine; D012837:Silver Sulfadiazine